Related Experiment Videos
Biomarkers in chronic obstructive pulmonary disease
1Department of Medicine, Division of Respiratory Medicine, the University of British Columbia and The Providence Heart and Lung Institute, James Hogg iCAPTURE Center, St Paul's Hospital, Vancouver, British Columbia, Canada. dsin@mrl.ubc.ca
Proceedings of the American Thoracic Society
|September 11, 2009
Summary
Developing new biomarkers for chronic obstructive pulmonary disease (COPD) is crucial. Current lung function tests are inadequate for evaluating novel COPD drugs, highlighting the need for better diagnostic tools.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) lacks validated biomarkers for drug efficacy testing.
- Current lung function tests are insufficient for short-term drug trials in COPD.
- Existing tests fail to reflect disease activity, COPD phenotypes, or treatment response.
Purpose of the Study:
- To discuss the challenges in discovering novel biomarkers for COPD.
- To propose criteria and methods for developing effective COPD biomarkers.
- To address the limitations of current diagnostic tools in COPD drug development.
Main Methods:
- Review of current literature on COPD biomarkers.
- Analysis of limitations of existing lung function tests.
- Discussion of proposed criteria for novel biomarker development.
Main Results:
- Lung function tests are not ideal surrogates for COPD drug efficacy.
- Significant barriers exist in the discovery of reliable COPD biomarkers.
- There is a clear need for validated biomarkers reflecting disease activity and phenotypes.
Conclusions:
- Novel, validated biomarkers are essential for advancing COPD drug development.
- Overcoming current barriers is key to identifying effective biomarkers.
- Future research should focus on developing biomarkers that capture COPD heterogeneity and therapeutic response.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...